OMX Nordic 40 2729754 / SE0001809476
2’455.41
Pkt
19.31
Pkt
0.79
%
09:48:05
Anzeige
Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
---|---|---|---|---|---|
Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
Marktkapitalisierung |
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu OMX Nordic 40-Werten
28.01.25 | ABB Underperform | Bernstein Research | |
28.01.25 | Novo Nordisk Buy | UBS AG | |
27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
27.01.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
27.01.25 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
24.01.25 | Novo Nordisk Buy | UBS AG | |
24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
24.01.25 | Ericsson Underweight | Barclays Capital | |
24.01.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
24.01.25 | Ericsson Sell | Goldman Sachs Group Inc. | |
24.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
24.01.25 | Ericsson Sell | UBS AG | |
23.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
23.01.25 | Volvo AB Neutral | UBS AG | |
22.01.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
21.01.25 | Novo Nordisk Buy | UBS AG | |
20.01.25 | ABB Underperform | Bernstein Research | |
20.01.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
17.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
17.01.25 | Novo Nordisk Buy | UBS AG | |
17.01.25 | Volvo AB Buy | Jefferies & Company Inc. | |
16.01.25 | Volvo AB Neutral | UBS AG | |
16.01.25 | Novo Nordisk Buy | UBS AG | |
16.01.25 | Ericsson Sell | Goldman Sachs Group Inc. | |
16.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
15.01.25 | Volvo AB Buy | Jefferies & Company Inc. | |
15.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
15.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
14.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
13.01.25 | Novo Nordisk Buy | UBS AG | |
13.01.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
13.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
13.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
12.01.25 | Ericsson Underperform | Bernstein Research | |
12.01.25 | Nokia Market-Perform | Bernstein Research | |
10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
10.01.25 | Novo Nordisk Buy | Deutsche Bank AG |